K

Knoll Capital Management, LP Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Knoll Capital Management, LP with $186.6M in long positions as of Q3 2025, 55% allocated to Healthcare, and 64% concentrated in top 10 positions.

Portfolio Value
$186.6M
Top 10 Concentration
64%
Top Sector
Healthcare (55%)
US Exposure
59%
Market Cap Focus
Small Cap
Countries
4

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 54.90%HealthcareBasic Materials: 32.50%Basic MaterialsIndustrials: 1.40%Financial Services: 0.90%Consumer Defensive: 0.90%ETF: 0.90%
Healthcare
54.90%
Basic Materials
32.50%
Industrials
1.40%
Financial Services
0.90%
Consumer Defensive
0.90%
ETF
0.90%

Industry Breakdown

10 industries across all sectors

Biotechnology: 49.98%BiotechnologyGold: 28.79%GoldDrug Manufacturers - Specialty & Generic: 4.97%Silver: 2.08%Other Precious Metals: 1.63%Financial - Credit Services: 0.89%4 more: 3.13%
Biotechnology
Healthcare
49.98%
Gold
Basic Materials
28.79%
Drug Manufacturers - Specialty & Generic
Healthcare
4.97%
Silver
Basic Materials
2.08%
Other Precious Metals
Basic Materials
1.63%
Financial - Credit Services
Financial Services
0.89%
Tobacco
Consumer Defensive
0.87%
ETF
ETF
0.86%
Aerospace & Defense
Industrials
0.71%
Consulting Services
Industrials
0.70%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mega Cap (> $200B): 1.76%Large Cap ($10B - $200B): 20.31%Large Cap ($10B - $200B)Mid Cap ($2B - $10B): 16.34%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 39.18%Small Cap ($300M - $2B)Micro Cap ($50M - $300M): 12.74%Micro Cap ($50M - $300M)N/A (ETF or Unknown): 9.68%N/A (ETF or Unknown)
Mega Cap (> $200B)
1.76%
Large Cap ($10B - $200B)
20.31%
Mid Cap ($2B - $10B)
16.34%
Small Cap ($300M - $2B)
39.18%
Micro Cap ($50M - $300M)
12.74%
N/A (ETF or Unknown)
9.68%

Portfolio Concentration

Top 10 Holdings %
64.11%
Top 20 Holdings %
90.04%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
58.73%
International
41.27%
Countries
4
Largest Int'l Market
Canada - 30.31%
United States of America
58.73% ($109.6M)
24 holdings
Canada
30.31% ($56.6M)
12 holdings
Israel
6.05% ($11.3M)
1 holdings
Ireland
4.91% ($9.2M)
1 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
14.2 quarters
Avg. Top 20
11.8 quarters
Avg. All Positions
9.6 quarters
Median Holding Period
8 quarters
Persistence Rate
73.68%
Persistent Holdings Weight
81.11%
Persistent Positions
28
Longest Held
Aldeyra Therapeutics, Inc. logo
Aldeyra Therapeutics, Inc.ALDX - 42 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
0.61%
Avg. Position Weight
2.63%
Largest Position
Aldeyra Therapeutics, Inc. logo
Aldeyra Therapeutics, Inc.ALDX - 15.32%
Largest Ownership Stake
Entera Bio Ltd. Ordinary Shares logo
Entera Bio Ltd. Ordinary SharesENTX - 12.88%
Avg. Ownership Stake
2.75%
Ownership Stake >5%
3
Ownership Stake >1%
6

Historical (Since Q2 2013)

Avg. New Position
3.20%
Avg. Ownership Stake
2.80%
Largest Position
Arcturus Therapeutics Holdings Inc. Common Stock logo
Arcturus Therapeutics Holdings Inc. Common StockARCT - 71.33% (Q4 2013)
Largest Ownership Stake
Entera Bio Ltd. Ordinary Shares logo
Entera Bio Ltd. Ordinary SharesENTX - 15.97% (Q4 2024)

Portfolio Turnover

Current Quarter

Turnover Ratio
6.5%
Value Traded
$12.08M
Positions Added
2
Positions Exited
3

Historical (Since Q2 2013)

Avg. Turnover Ratio
7.9%
Avg. Positions Added
3
Avg. Positions Exited
2
Highest Turnover
56.8%
Q4 2022

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.